Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LACTOSE INDIA vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LACTOSE INDIA GLENMARK PHARMA LACTOSE INDIA/
GLENMARK PHARMA
 
P/E (TTM) x 33.2 -31.4 - View Chart
P/BV x 4.3 2.9 151.5% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 LACTOSE INDIA   GLENMARK PHARMA
EQUITY SHARE DATA
    LACTOSE INDIA
Mar-23
GLENMARK PHARMA
Mar-23
LACTOSE INDIA/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs96487 19.8%   
Low Rs39349 11.2%   
Sales per share (Unadj.) Rs52.3460.4 11.4%  
Earnings per share (Unadj.) Rs1.013.4 7.2%  
Cash flow per share (Unadj.) Rs4.735.0 13.4%  
Dividends per share (Unadj.) Rs02.50 0.0%  
Avg Dividend yield %00.6 0.0%  
Book value per share (Unadj.) Rs32.2335.1 9.6%  
Shares outstanding (eoy) m12.59282.17 4.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.30.9 142.9%   
Avg P/E ratio x70.631.3 225.9%  
P/CF ratio (eoy) x14.511.9 121.4%  
Price / Book Value ratio x2.11.2 168.7%  
Dividend payout %018.7 0.0%   
Avg Mkt Cap Rs m854117,953 0.7%   
No. of employees `000NANA-   
Total wages/salary Rs m12227,810 0.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m658129,901 0.5%  
Other income Rs m73,168 0.2%   
Total revenues Rs m665133,069 0.5%   
Gross profit Rs m11515,125 0.8%  
Depreciation Rs m476,113 0.8%   
Interest Rs m603,496 1.7%   
Profit before tax Rs m158,685 0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m34,911 0.1%   
Profit after tax Rs m123,774 0.3%  
Gross profit margin %17.411.6 149.5%  
Effective tax rate %17.556.5 30.9%   
Net profit margin %1.82.9 63.2%  
BALANCE SHEET DATA
Current assets Rs m37598,737 0.4%   
Current liabilities Rs m26650,455 0.5%   
Net working cap to sales %16.637.2 44.7%  
Current ratio x1.42.0 72.1%  
Inventory Days Days467 680.0%  
Debtors Days Days693115 601.8%  
Net fixed assets Rs m64376,920 0.8%   
Share capital Rs m126282 44.6%   
"Free" reserves Rs m28094,281 0.3%   
Net worth Rs m40694,563 0.4%   
Long term debt Rs m33038,521 0.9%   
Total assets Rs m1,018175,658 0.6%  
Interest coverage x1.23.5 35.7%   
Debt to equity ratio x0.80.4 200.0%  
Sales to assets ratio x0.60.7 87.4%   
Return on assets %7.14.1 172.0%  
Return on equity %3.04.0 74.7%  
Return on capital %10.29.2 111.3%  
Exports to sales %00-   
Imports to sales %31.30-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m206NA-   
Fx inflow Rs m10446,464 0.2%   
Fx outflow Rs m20912,712 1.6%   
Net fx Rs m-10533,751 -0.3%   
CASH FLOW
From Operations Rs m816,254 1.3%  
From Investments Rs m-10-5,285 0.2%  
From Financial Activity Rs m-84-775 10.8%  
Net Cashflow Rs m-13325 -4.1%  

Share Holding

Indian Promoters % 53.7 46.7 115.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.6 34.7 1.8%  
FIIs % 0.0 23.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 46.3 53.4 86.9%  
Shareholders   16,088 209,931 7.7%  
Pledged promoter(s) holding % 26.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LACTOSE INDIA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on LACTOSE INDIA vs Glenmark Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

LACTOSE INDIA vs Glenmark Pharma Share Price Performance

Period LACTOSE INDIA Glenmark Pharma S&P BSE HEALTHCARE
1-Day -1.83% -0.57% 1.18%
1-Month -2.41% 5.16% -0.75%
1-Year 226.47% 112.94% 61.82%
3-Year CAGR 73.96% 27.51% 18.16%
5-Year CAGR 33.74% 8.05% 19.79%

* Compound Annual Growth Rate

Here are more details on the LACTOSE INDIA share price and the Glenmark Pharma share price.

Moving on to shareholding structures...

The promoters of LACTOSE INDIA hold a 53.7% stake in the company. In case of Glenmark Pharma the stake stands at 46.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of LACTOSE INDIA and the shareholding pattern of Glenmark Pharma.

Finally, a word on dividends...

In the most recent financial year, LACTOSE INDIA paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

Glenmark Pharma paid Rs 2.5, and its dividend payout ratio stood at 18.7%.

You may visit here to review the dividend history of LACTOSE INDIA, and the dividend history of Glenmark Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.